The RelB-BLNK Axis Determines Cellular Response to a Novel Redox-Active Agent Betamethasone during Radiation Therapy in Prostate Cancer is a research paper published in International Journal of Molecular Sciences (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R01 CA205400
NIH
Grant: P20 GM121327
NIH
Grant: R01 CA251663
NIH
Grant: UL1TR000117
NIH
Grant: UL1TR001998
NIH
Grant: P30 CA177558
NCI NIH HHS
Grant: CA177558
NCI NIH HHS
Grant: CA205400
NIGMS NIH HHS
Grant: GM121327
National Institutes of Health
Grant: 5UL1TR000117-04
Kentucky Center for Clinical and Translational Science
National Institutes of Health
Grant: 1R01CA205400-01
Distinct Redox Mechanism in Normal and Cancer Cells as a Novel Therapeutic Target
National Institutes of Health
Grant: 5UL1TR001998-02
Kentucky Center for Clinical and Translational Science
National Institutes of Health
Grant: 1R01CA251663-01A1
Targeting Mitochondrial Redox Capacity to Overcome Cancer Subtype that Regrowth After Radiation
National Institutes of Health
Grant: 3P30CA177558-01S1
CTRP Supplement
National Institutes of Health
Grant: 1P20GM121327-01
University of Kentucky Center for Cancer and Metabolism
FWCI
0.31
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals